Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes

    Sanofi and Bristol-Myers Squibb are promoting Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes.

    Plavix is a new platelet inhibitor. It's similar to Ticlid (ticlopidine)...but without the risk of neutropenia.

    Plavix is slightly more effective than aspirin...and causes slightly less GI bleeding.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote